Nazema Y. Siddiqui, MD, MHSc (she/her/hers)

Associate Professor, Urogynecology and Reconstructive Pelvic Surgery
Duke University
Durham, North Carolina, United States

Nazema Y. Siddiqui, MD, MHSc, is an Associate Professor in the Department of Obstetrics & Gynecology, Division of Urogynecology & Reconstructive Pelvic Surgery at Duke University (Durham, North Carolina, USA). Her research focuses on the translational biology of urologic disorders that are common in postmenopausal women, such as overactive bladder (OAB), urgency urinary incontinence (UUI), and recurrent urinary tract infections (UTIs). For these issues, the urinary microbiome has been implicated as a potential causative or exacerbating factor. Therefore, her research group has been characterizing age-related changes in the urinary microbiome and working to understand the associations that are seen between microbiota and urinary symptom disorders.

Presentation(s):

• BEST RESIDENT/STUDENT PAPER: Aging and the Female Urinary Microbiome: Associations between Lactobacilli, menopause and vaginal estrogen use

  Thursday, October 5, 2023
  11:45 AM – 11:55 AM US PST

  Disclosure(s): Ethicon J&J: Research funding (Ongoing); Frontiers Media: Specialty Chief Editor (Ongoing); Medtronic Inc: Research funding (Ongoing)

• Mini State of the Art: Recurrent UTIs and the Microbiome

  Thursday, October 5, 2023
  12:10 PM – 12:30 PM US PST

  Disclosure(s): Ethicon J&J: Research funding (Ongoing); Frontiers Media: Specialty Chief Editor (Ongoing); Medtronic Inc: Research funding (Ongoing)

• NIH Panel: Securing Research Funding - Secrets to Success (separate ticket required)

  Friday, October 6, 2023
  7:00 AM – 7:55 AM US PST

  Disclosure(s): Ethicon J&J: Research funding (Ongoing); Frontiers Media: Specialty Chief Editor (Ongoing); Medtronic Inc: Research funding (Ongoing)

• Mini State of the Art: Collaborations between AUGS and federal funding agencies on urinary incontinence

  Friday, October 6, 2023
  2:45 PM – 3:05 PM US PST

  Disclosure(s): Ethicon J&J: Research funding (Ongoing); Frontiers Media: Specialty Chief Editor (Ongoing); Medtronic Inc: Research funding (Ongoing)

• Initial validation of AUGS-PERFORM: Construct validity and test-retest reliability

  Friday, October 6, 2023
  3:09 PM – 3:13 PM US PST

  Disclosure(s): Ethicon J&J: Research funding (Ongoing); Frontiers Media: Specialty Chief Editor (Ongoing); Medtronic Inc: Research funding (Ongoing)